Soja: ROSARIO
$395.000 1.54%
Maíz: ROSARIO
$241.100 -0.04%
Trigo: ROSARIO
$272.000 -0.66%
By Agroempresario.com
In the heart of Brazil’s scientific innovation, a revolutionary biotech company is leading the next phase in agricultural gene editing. InEdita Bio, founded by Dr. Paulo Arruda, geneticist at the State University of Campinas (UNICAMP), is pioneering a new paradigm for sustainable crop production by merging plant and microbial genetics through CRISPR-Cas9 technology.
This “Gene Editing 2.0” initiative reflects a profound shift in how agriculture may confront its greatest challenges—from climate stress to disease pressure—by precisely manipulating plant genomes and their microbial allies.
Gene editing, especially with CRISPR-Cas9 technology, enables targeted, efficient, and cost-effective modifications in plant genomes. Rather than introducing foreign DNA like traditional GMOs, CRISPR makes precise “edits” to a plant’s native genetic code. For Dr. Arruda, this technology isn’t just a lab breakthrough—it’s a necessity.
“The way we produce food nowadays is not sustainable,” he asserts. “Twenty percent of grains are lost to fungi and pests, despite massive pesticide use. We need alternatives.”
CRISPR offers those alternatives. Using guide RNAs, scientists can target and tweak genes that determine whether a crop succumbs to or resists disease. This allows crops to transition from vulnerability to resilience—often by reinstating natural alleles lost during decades of breeding focused on yield.
Agriculture in Brazil presents unique challenges—and opportunities. From the arid savannas of Central Brazil to the wetter climates of the south, more than 200 commercial corn hybrids span vastly different ecosystems. To address traits like drought resistance, InEdita Bio must consider both plant genetic diversity and environmental complexity.
But InEdita goes beyond plants.
“Plants do not grow alone. They live with thousands of microorganisms that help with stress, drought, and disease resistance,” says Dr. Arruda.
That insight underpins a radical vision: integrating microbial genome editing alongside plant gene editing to enhance symbiotic performance. InEdita is already experimenting with making crops more compatible with beneficial microbes like nitrogen-fixing bacteria, which are central to Brazil’s success with soybean cultivation.
“In Brazil, soybeans fix nitrogen naturally thanks to Bradyrhizobium strains. The goal now is: can we get other crops to do the same?”
One of InEdita’s significant achievements is avoiding the cumbersome tissue culture step traditionally needed in plant modification. Instead, they use particle bombardment: microscopic gold particles are coated with DNA and launched into plant cells. The result? Gene-edited seeds—faster and cheaper than before.
For certain applications, they also deploy RNA interference (RNAi), a natural mechanism that silences specific genes in pests or pathogens. By engineering non-coding regions of plant DNA, they enable plants to produce RNA molecules that neutralize disease-causing agents.
This two-pronged approach—CRISPR and RNAi—enables a range of solutions from boosting drought resistance to combating pathogens like Phakopsora pachyrhizi, the fungus behind Asian Soybean Rust (ASR), a devastating disease that costs farmers billions annually.
“We received a grant from FINEP to develop ASR-resistant soybean. But this model can help other crops too.”
Rather than going to market directly, InEdita Bio licenses its technologies to seed companies. These partners get access to elite traits, while InEdita retains its focus on innovation and platform development.
“We’re working with two corn seed companies in co-development agreements,” says Dr. Arruda. “They help fund trait development and then pay royalties.”
This model allows flexibility, speed, and impact without the heavy investment needed for direct seed production.
Brazil is emerging as a global leader in gene editing regulation. The National Technical Commission on Biosafety (CTNBio) has already approved CRISPR-edited soybeans that don’t qualify as GMOs under current law.
“We’re still early, but there are already CRISPR crops cleared for commercialization,” Arruda notes. “If nature could do it—why regulate it as a transgene?”
This regulatory flexibility accelerates time to market, opening doors for companies like InEdita to deliver faster solutions to urgent agricultural problems.
Gene editing is no longer a laboratory dream—it’s becoming an industrial tool. With advancements in computational biology, AI, and machine learning, breeders can now “read” and “rewrite” the plant genome like a text, inserting resilience traits lost in past selection cycles.
“We call it industrial genetics,” says Dr. Arruda. “You correct alleles lost through breeding—resistance to drought, salinity, pathogens—and bring it all together.”
Imagine mining wild plant populations that thrive in deserts or nutrient-poor soils, identifying their genetic survival traits, and introducing those into commercial crops. That’s InEdita’s next frontier.
InEdita Bio stands at the nexus of biotechnology’s two most promising domains: plant editing and microbial symbiosis. By aligning these once-separate fields, Dr. Arruda envisions a food system that is resilient, sustainable, and less reliant on chemicals.
Brazil, with its vast agricultural landscape and biodiversity, may just become the proving ground for this model. If successful, the combination of gene editing and microbial engineering could redefine global food production in the coming decades.
“This is not just about new technology,” concludes Arruda. “It’s about changing the way we think about agriculture—from a battle against nature to a partnership with it.”
